Wen Zhong

504 total citations
18 papers, 394 citations indexed

About

Wen Zhong is a scholar working on Molecular Biology, Cancer Research and Cellular and Molecular Neuroscience. According to data from OpenAlex, Wen Zhong has authored 18 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Cancer Research and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Wen Zhong's work include Epigenetics and DNA Methylation (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wen Zhong is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), MicroRNA in disease regulation (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). Wen Zhong collaborates with scholars based in China, Macao and Hong Kong. Wen Zhong's co-authors include Guohua Zeng, Shan Gao, Zhisheng Xiao, Qifang Lei, Ziliang Dong, Guangzhi Li, Zhuang Liu, Dashi Deng, Zhiping Wang and Xinhua Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and Hypertension.

In The Last Decade

Wen Zhong

16 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wen Zhong China	9	181	161	89	65	59	18	394
Yuan‐Qiu Cheng China	6	261 1.4×	147 0.9×	103 1.2×	35 0.5×	36 0.6×	11	409
Xiaosheng Lin China	10	133 0.7×	176 1.1×	71 0.8×	43 0.7×	69 1.2×	24	388
Xiying Dong China	10	120 0.7×	150 0.9×	63 0.7×	35 0.5×	58 1.0×	22	403
Xisheng Wang China	10	206 1.1×	153 1.0×	116 1.3×	44 0.7×	63 1.1×	20	468
Ruihao Li China	12	180 1.0×	116 0.7×	49 0.6×	56 0.9×	102 1.7×	33	429
Wen Song China	11	226 1.2×	108 0.7×	147 1.7×	88 1.4×	96 1.6×	34	500
Yabing Dong China	11	175 1.0×	166 1.0×	100 1.1×	54 0.8×	178 3.0×	22	459
Yang Peng United States	9	216 1.2×	90 0.6×	127 1.4×	66 1.0×	44 0.7×	11	371
Xiangting Xu China	10	127 0.7×	143 0.9×	63 0.7×	88 1.4×	23 0.4×	13	330

Countries citing papers authored by Wen Zhong

Since Specialization

Citations

This map shows the geographic impact of Wen Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Zhong more than expected).

Fields of papers citing papers by Wen Zhong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Zhong. The network helps show where Wen Zhong may publish in the future.

Co-authorship network of co-authors of Wen Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Zhong. A scholar is included among the top collaborators of Wen Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Zhong. Wen Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Zhang, Yuyu, Wen Zhong, Subei Tan, et al.. (2025). Procyanidin B3 and Its Derivatives Alleviate Neuronal Injury by Targeting G3BP1 for Ischemic Stroke Therapy. Advanced Science. 12(45). e09781–e09781.

Chen, Honghong, Jie Xu, Qiuyuan Huang, et al.. (2025). Kif23 Promotes Myocardial Fibrosis by Suppressing Ces1d-Dependent Lipid Metabolism. Hypertension. 83(1). 116–129.

Zhang, Yuqin, et al.. (2025). Glioblastoma-associated macrophages in glioblastoma: from their function and mechanism to therapeutic advances. Cancer Gene Therapy. 32(6). 595–607. 3 indexed citations

Zhong, Wen, et al.. (2025). SETD7 drives diabetic endothelial dysfunction through FBXO45-mediated GPX4 ubiquitylation. Cardiovascular Diabetology. 24(1). 178–178. 5 indexed citations

Su, Zhenghua, Jinghuan Wang, Chenxi Xiao, et al.. (2024). Functional role of Ash2l in oxLDL induced endothelial dysfunction and atherosclerosis. Cellular and Molecular Life Sciences. 81(1). 62–62. 4 indexed citations

Zhong, Wen, Hong Chen, Yuyu Zhang, et al.. (2023). ASH2L-mediated H3K4me3 drives diabetic nephropathy through HIPK2 and Notch1 pathway. Translational research. 264. 85–96. 4 indexed citations

Zhong, Wen, Hong Chen, Yuhui Li, et al.. (2023). ASH2L upregulation contributes to diabetic endothelial dysfunction in mice through STEAP4-mediated copper uptake. Acta Pharmacologica Sinica. 45(3). 558–569. 8 indexed citations

Yang, Di, Peng Xu, Wen Zhong, et al.. (2022). The histone methyltransferase DOT1L is a new epigenetic regulator of pulmonary fibrosis. Cell Death and Disease. 13(1). 60–60. 23 indexed citations

Xu, Jie, Jinghuan Wang, Fen Long, et al.. (2022). Inhibition of the cardiac fibroblast-enriched histone methyltransferase Dot1L prevents cardiac fibrosis and cardiac dysfunction. Cell & Bioscience. 12(1). 134–134. 9 indexed citations

10.

Wang, Jinghuan, et al.. (2022). Histone methyltransferase Smyd2 contributes to blood‐brain barrier breakdown in stroke. Clinical and Translational Medicine. 12(3). e761–e761. 17 indexed citations

11.

Zhong, Wen, et al.. (2022). ASH2L Aggravates Fibrosis and Inflammation through HIPK2 in High Glucose-Induced Glomerular Mesangial Cells. Genes. 13(12). 2244–2244. 7 indexed citations

12.

Wu, Weijun, Jinghuan Wang, Chenxi Xiao, et al.. (2021). SMYD2‐mediated TRAF2 methylation promotes the NF‐κB signaling pathways in inflammatory diseases. SHILAP Revista de lepidopterología. 11(11). e591–e591. 27 indexed citations

13.

Wang, Jinghuan, et al.. (2021). Histone Methyltransferase Dot1L Contributes to RIPK1 Kinase‐Dependent Apoptosis in Cerebral Ischemia/Reperfusion. Journal of the American Heart Association. 10(23). e022791–e022791. 14 indexed citations

14.

Zhong, Wen, et al.. (2020). Knockdown of lncRNA PVT1 alleviates high glucose-induced proliferation and fibrosis in human mesangial cells by miR-23b-3p/WT1 axis. Diabetology & Metabolic Syndrome. 12(1). 33–33. 26 indexed citations

15.

Li, Guangzhi, Dashi Deng, Zhisheng Xiao, et al.. (2020). Fluorinated Chitosan To Enhance Transmucosal Delivery of Sonosensitizer-Conjugated Catalase for Sonodynamic Bladder Cancer Treatment Post-intravesical Instillation. ACS Nano. 14(2). 1586–1599. 203 indexed citations

16.

Cai, Chao, Huichan He, Xiaolu Duan, et al.. (2018). miR-195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression. Oncology Reports. 39(4). 1658–1670. 37 indexed citations

17.

Zhong, Wen, et al.. (2013). [Expression of miR-143 in nasopharyngeal carcinoma cell lines and its effect on cell adhesion ability].. PubMed. 33(4). 582–5. 2 indexed citations

18.

Zhong, Wen, et al.. (2013). [MiR-143 inhibits migration of human nasopharyngeal carcinoma cells by negatively regulating GLI3 gene].. PubMed. 33(7). 1057–61. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact